市场调查报告书
商品编码
1467690
2024-2032 年按设备类型、最终用户和地区分類的周边血管设备市场报告Peripheral Vascular Devices Market Report by Device Type, End User, and Region 2024-2032 |
2023年,全球IMARC Group血管器械市场规模达1,16亿美元。
週边血管疾病 (PVD) 是由于心臟和大脑外部血管狭窄、阻塞或痉挛而引起的循环系统疾病。这种情况会减少血管中的血流量,导致虚弱、疼痛、坏疽、腿部除毛、麻木和肌肉沉重。週边血管装置,如血管成形术导管、週边导丝、腔静脉过滤器、支架移植物和栓塞保护装置 (EPD),用于治疗动脉阻塞和狭窄。这些阻塞,尤其是在周边脉管系统中发现的阻塞,是由斑块堆积引起的,斑块堆积限制了血管并减少了流向身体部位的血流。週边血管装置是安全的,可以最大限度地减少感染和刺激的风险,改善血流,并透过动脉供应含氧血液。
全球静脉疾病或 CVI(慢性静脉功能不全)的盛行率不断上升,为市场创造了积极的前景。週边血管装置为大脑、腿部和足部提供充足的血流,以确保正常功能。此外,老年人口的增加以及週边动脉疾病(PAD)和阻塞等各种疾病发病率的增加也有利于市场的成长。此外,这可以归因于生活习惯的改变,包括吸烟和大量饮酒,再加上缺乏身体活动和不健康的饮食习惯。除此之外,由于併发症更少、术后疼痛更少、住院时间更短和恢復时间更快,人们越来越倾向于微创手术(MIS),这也推动了市场的成长。此外,由于动脉粥状硬化、肥胖和生活方式相关疾病的日益流行,斑块切除装置的广泛采用正在对市场成长产生积极影响。其他因素,包括医疗保健行业的显着增长、消费者支出能力的提高以及广泛的研发 (R&D) 活动,预计将推动市场成长。
The global peripheral vascular devices market size reached US$ 11.6 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 19.8 Billion by 2032, exhibiting a growth rate (CAGR) of 5.9% during 2024-2032.
Peripheral vascular disease (PVD) is a circulatory condition caused due to the narrowing, blockage, or spasms in the blood vessels located outside the heart and brain. Such occurrences reduce the blood flow through the vessels, resulting in weakness, pain, gangrene, hair loss on the legs, numbness, and muscle heaviness. Peripheral vascular devices, such as angioplasty catheters, peripheral guidewires, vena cava filters, stent grafts, and embolic protection devices (EPD), are used to treat artery blockages and narrowing. These blockages, particularly found in the peripheral vasculature, are caused by plaque build-up, which limits the blood vessels and reduces blood flow to the body parts. Peripheral vascular devices are safe, minimize the risk of infection and irritation, improve blood flow, and supply oxygenated blood through arteries.
The increasing prevalence of venous diseases or CVI (chronic venous insufficiency) across the globe is creating a positive outlook for the market. Peripheral vascular devices provide sufficient blood flow to the brain, legs, and feet for proper functioning. Additionally, the rising geriatric population and the increasing incidences of various ailments, such as peripheral artery disease (PAD) and blockages, are favoring the market growth. Furthermore, this can be attributed to changing lifestyle habits, including smoking and high alcohol consumption, coupled with physical inactivity and unhealthy dietary habits. Apart from this, the growing inclination toward minimally invasive surgeries (MIS) due to fewer complications, less postoperative pain, shortened hospital stay, and faster recovery times are providing an impetus to the market growth. Moreover, the widespread adoption of atherectomy devices owing to the increasing prevalence of atherosclerosis, obesity, and lifestyle-related disorders is positively influencing the market growth. Other factors, including the significant growth in the healthcare industry, rising expenditure capacities of consumers, and extensive research and development (R&D) activities, are anticipated to drive the market toward growth.
IMARC Group provides an analysis of the key trends in each sub-segment of the global peripheral vascular devices market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on device type and end user.
Peripheral Vascular Stents
Peripheral Transluminal Angioplasty (PTA) Balloon Catheters
Peripheral Transluminal Angioplasty (PTA) Guidewires
Atherectomy Devices
Embolic Protection Devices
Inferior Vena Cava Filters
Others
Hospitals and Clinics
Ambulatory Care Centers
Specialty Clinics
Others
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, B. Braun SE (B. Braun Holding GmbH & Co. KG), Becton, Dickinson and Company, Biotronik SE & Co. KG, Boston Scientific Corporation, Cook Group Incorporated, Cordis Corporation, iVascular S.L.U., Koninklijke Philips N.V., Medtronic plc and Terumo Medical Corporation.